In addition, we previously reported that ErbB2 signaling epigenetically suppresses miR-205-5p transcription via the Ras/Raf/MEK/ERK pathway in breast cancer (Hasegawa et al., 2017). The gene discussed is ERBB2; the disease is breast carcinoma.